 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PETACH TIKVA,Israel, Feb. 28, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), ( PolyPid or the Company ), a late-stage biopharma company aiming to improve surgical outcomes, today...

PolyPid to Participate in Barclays 26th Annual Global Healthcare Conference

PolyPid GAAP EPS of -$3.97 misses by $1.18...

PolyPid GAAP EPS of -$3.97 misses by $1.18

More Than 100 Patients Enrolled in Ongoing SHIELD II Phase 3 Trial of D-PLEX100 for the Prevention of Abdominal Colorectal Surgical Site Infections Unblinded Interim Analysis to be Conducted Once...

PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

PolyPid Ltd (PYPD) Q4 2023 Earnings Call Transcript...

PolyPid Ltd (PYPD) Q4 2023 Earnings Call Transcript

Approximately 40 Centers Currently Open Unblinded Interim Analysis to be Conducted Once Approximately 400 Patients Complete Their 30-Day Follow-up; Top-line Results Expected in Second Half of 2024...

PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

PolyPid files to sell 6.74M ordinary shares for holders

PETACH TIKVA,Israel, Jan. 31, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ( PolyPid or the Company ), a late-stage biopharma company aiming to improve surgical outcomes, today...

PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on February 14, 2024

PolyPid (NASDAQ:PYPD  Get Free Report) and Assure (NASDAQ:IONM  Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two...

PolyPid (NASDAQ:PYPD) and Assure (NASDAQ:IONM) Head to Head Comparison

Assure (NASDAQ:IONM  Get Free Report) and PolyPid (NASDAQ:PYPD  Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two...

Reviewing PolyPid (NASDAQ:PYPD) and Assure (NASDAQ:IONM)

Financing Led by Leading U.S. Life Sciences-focused InvestorsPETACH TIKVA,Israel, Jan. 04, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ( PolyPid or the Company ), a late-stage...

PolyPid Announces Private Placement for $16 Million in Gross Proceeds

PolyPid Ltd. operates as a phase 3 biopharma company. Its proprietary PLEX technology pairs with medications, enables precise delivery of drugs at effective release rates, over pre-determined durations ranging from several days to months. The firm's product candidates are designed to address unmet medical needs by delivering active pharmaceutical ingredients, or APIs, locally at predetermined release rates and durations over extended periods ranging from days to several months. The company was founded by Noam Emanuel on February 28, 2008 and is headquartered in Petach Tikva, Israel.

Volume (M)	1,310.00
52-Wk High	$13.50
52-Wk Low	$3.57

PYPD Polypid Ltd

About

Feed

News

Sentiment

Earnings

Fundamentals